Longport Stock

Longport Equity

The The Equity of Longport (LPTI) as of Aug 15, 2026 is 903,873.00 USD.

Equity

903,873.00USD

Last updated:

In 2026, Longport's equity was 903,873.00 USD, a % increase from the - USD equity in the previous year.

Access this data via the Eulerpool API

Longport Stock analysis

What does Longport do? Longport Inc is a US-based company specializing in the development, manufacturing, and marketing of medical devices. It was founded in 1998 by a group of engineers and businesspeople with a vision to create devices that make medical treatments more effective and safer. The business model of Longport Inc is based on providing customized solutions for medical applications. The company offers a wide range of products and services focusing on various medical fields such as radiology, urology, neurology, gastroenterology, and cardiology. Another focus is on developing products for the treatment of vascular diseases. The company follows a customer-oriented philosophy tailored to the needs of its customers. It works closely with hospitals and other healthcare facilities and has built partnerships with medical device companies worldwide. Longport Inc is headquartered in New Jersey, USA, and has branches in Europe and Asia. It employs a wide range of professionals including engineers, scientists, salespeople, and managers. In terms of its various product divisions, Longport Inc is best known for its medical imaging products. The company has developed a range of products that contribute to improving the accuracy and effectiveness of X-ray and ultrasound images. These include image processing software, detectors, and other accessories. In urology, Longport Inc has developed a wide range of products supporting the diagnosis and treatment of prostate diseases. This includes devices such as the transrectal ultrasound probe and the prostate biopsy needle. In neurology, the company offers devices for the diagnosis and treatment of brain injuries and diseases. These range from stereotactic devices used for deep brain stimulation procedures to devices used for measuring brain waves. In the field of gastroenterology, Longport Inc provides products for the diagnosis and treatment of gastrointestinal inflammation, as well as for the treatment of stomach ulcers and other stomach issues. Finally, the company also develops products for other medical applications beyond its core areas. These include devices for monitoring blood pressure, measuring blood glucose levels, and treating heart diseases. Over the years, Longport Inc has received several awards for its innovative products and exceptional achievements in the field of medical device manufacturing. The company is committed to continuing to develop innovative solutions for the medical industry to improve patient treatment worldwide. Longport is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Longport's Equity

Longport's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Longport's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Longport's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Longport's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Longport’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Longport stock

The Equity of Longport is 903,873.00 USD in 2026.

On Eulerpool you can find the complete historical development of The Equity Longport since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Longport historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Longport

All Key Metrics — Longport